CTRI/2017/08/009227已完成2 期
An Open, Prospective, Comparative Study to Assess the Efficacy and Safety of Pudin Hara Pearls & Liquid in the Management of Indigestion
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 79
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects suffering from functional dyspepsia i.e. indigestion and its related signs and symptoms such as fullness, bloating, nausea, gassy discomfort, loss of appetite, spasm and pain in the chest or abdomen for at least on two occasions in the preceding week and were having normal hepatic and renal functions (LFT & RFT)
排除标准
- •Subjects with persistent dyspepsia, vomiting, severe epigastric pain unintentional weight loss, iron deficiency anemia, gastro-intestinal bleeding, dysphasia, odynophagia, previous gastric surgery, epigastric mass, suspicious barium meal, peptic ulcer, and NSAID use. Organic deformity or malignancy of the GI tract, significant systemic and psychological condition (s) which may hamper the study proceedings, conditions requiring immediate surgical intervention, known hypersensitivity to study product or ingredient (s), concomitant medications known to adversely interact with study products or their ingredients, alcohol or drug abuse, pregnancy, lactation and females planning to conceive in near future
研究者
相似试验
进行中（未招募）
不适用
An Open-Label, Non-Comparative Study to Assess the Pharmacokinetics, Safety and Efficacy of Topical Retapamulin (SB-275833) Ointment, 1%, Twice Daily for Five Days in the Treatment of Uncomplicated Skin and Skin Structure Infections in Pediatric Subjects Aged 2 to 24 Monthsncomplicated skin and skin structure infectionsEUCTR2006-003374-10-NLGlaxoSmithKline Research & Development Ltd60
进行中（未招募）
不适用
An Open-Label, Non-Comparative Study to Assess the Pharmacokinetics, Safety and Efficacy of Topical Retapamulin (SB-275833) Ointment, 1%, Twice Daily for Five Days in the Treatment of Uncomplicated Skin and Skin Structure Infections in Pediatric Subjects Aged 2 to 24 MonthsEUCTR2006-003374-10-DEGlaxoSmithKline Research & Development Ltd60
已完成
不适用
Clinical Evaluation of Efficacy & Safety of DRF/AY/5003 in comparison with marketed drug in AcneCTRI/2018/03/012727Dabur India Limited86
进行中（未招募）
不适用
An open, prospective, randomized, comparative study to evaluate the effect of Iodixanol 320 compared to Iomeprol 350 on contrast medium induced nephropathy in patients with impaired renal function undergoing percutaneous coronary intervention - CONTRASTPatients with symptomatic coronary artery disease, impaired renal function (GFR<60ml/min) undergoing percutaneous coronary interventionEUCTR2005-003832-24-DEDeutsches Herzzentrum München900
尚未招募
4 期
Pulmonary Artery Remodelling With BosentaHypertension, PulmonaryCardiovascular - HypertensionACTRN12606000289516Actelion Phrmaceuticals Australia15